Abstract
No public abstract is available from the verified source records.
Taryn Youngstein, Brittany Weber, Maya H Buch
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
2025 ESC guidelines for the management of myocarditis and pericarditis
10.1093/eurheartj/ehaf192 · 2025
Immune-mediated diseases and risk of incident cardiovascular diseases: a prospective cohort study
10.1093/rheumatology/kead266 · 2024
Current understanding and management of cardiovascular involvement in rheumatic immune-mediated inflammatory diseases
10.1038/s41584-024-01149-x · 2024
Trends in cardiovascular disease incidence among 22 million people in the UK over 20 years: population based study
10.1136/bmj-2023-078523 · 2024
Cardiovascular manifestations in idiopathic inflammatory myopathies
10.1007/s10067-023-06599-4 · 2023
Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study
10.1093/oxfordjournals.aje.a009122 · 1997
Heart and systemic sclerosis-findings from a national cohort study
10.1093/rheumatology/kead599 · 2024
Diagnostic criteria, severity classification and guidelines of systemic sclerosis
10.1111/1346-8138.14162 · 2018
Cardiac Involvement in Eosinophilic Granulomatosis with Polyangiitis
10.1007/s11886-025-02258-z · 2025
Predictors of subclinical systemic sclerosis primary heart involvement characterised by microvasculopathy and myocardial fibrosis
10.1093/rheumatology/keaa742 · 2021
Myocardial T2 mapping by cardiovascular magnetic resonance reveals subclinical myocardial inflammation in patients with systemic lupus erythematosus
10.1007/s10554-014-0560-3 · 2015
Immunological pathogenesis and treatment of systemic lupus erythematosus
10.1007/s12519-019-00229-3 · 2020
Idiopathic inflammatory myopathies: clinical approach and management
10.3389/fneur.2016.00064 · 2016
Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations
10.1016/j.jacc.2018.09.072 · 2018
Tailored therapeutic decision of rheumatoid arthritis using proteomic strategies: how to start and when to stop?
10.1186/s12014-023-09411-2 · 2023
Anti-dsDNA antibodies increase the cardiovascular risk in systemic lupus erythematosus promoting a distinctive immune and vascular activation
10.1161/atvbaha.121.315928 · 2021
Diagnostic utility of the revised Lake Louise criteria in myocarditis associated with active autoimmune rheumatic disease
10.1016/j.jocmr.2025.101916 · 2025
Prognostic significance of pericardial effusion in systemic sclerosis-associated pulmonary hypertension: analysis from the PHAROS Registry
10.1093/rheumatology/kead368 · 2024
Cardiac Involvement in Eosinophilic Granulomatosis with Polyangiitis
10.1007/s11886-025-02258-z · 2025
Rationale and design of EACVI-INFLAME study: an international registry on multimodality imaging for suspicion of cardiovascular involvement due to inflammatory or autoimmune rheumatic diseases
10.1016/j.acvd.2025.10.109 · 2026
No additional external references are available.